Shire’s Chief Executive Officer, Flemming Ornskov, MD will present at the Morgan Stanley Global Healthcare Conference Monday, September 9th, 2013 at 3:50 PM EDT/20:50 BST. Investors may access a live audio webcast of the presentation at
For further information please contact:
+1 781 482 0999
+44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.